On-line solid phase extraction coupled to capillary LC-ESI-MS for determination of fluoxetine in human blood plasma

An instrumental setup including on-line solid phased extraction coupled to capillary liquid chromatography-electrospray ionization-mass spectrometry (SPE-capLC-ESI-MS) has been constructed to improve the sensitivity for quantification of fluoxetine hydrochloride in human plasma. Prior to injection, 0.5 mL of plasma spiked with metronidazole (internal standard) was mixed with ammonium formate buffer for effective chloroform liquid–liquid extraction. The method was validated in the range 5–60 ng mL−1 fluoxetine, yielding a correlation coefficient of 0.999 (r2). The within-assay and between-assay precisions were between (8.5 and 11%) and (6.6 and 7.5%), respectively. The method was used to determine the amount of fluoxetine in a healthy male 14 h after an intake of one capsule of the antidepressant and anorectic Flutin®, which contains 20 mg fluoxetine per each capsule. Fluoxetine was detected, and the concentration was calculated to 9.0 ng mL−1 plasma. In the preliminary experiments, conventional LC–UV instrumentation was employed. However, it was found that employing a capillary column with an inner diameter of (0.3 mm I.D. × 50 mm, Zorbax C18) increased the sensitivity by a factor of ∼100, when injecting the same mass of analyte. Incorporating an easily automated C18 reversed phase column switching system with SPE (1.0 mm I.D. × 5.0 mm, 5 μm) made it possible to inject up to 100 μL of solution, and the total analysis time was 5.5 min.